FDA Inspection 1274884 — Shandong Lukang Shelile Pharmaceutical Co., Ltd.

Shandong Lukang Shelile Pharmaceutical Co., Ltd. — FEI 3001040579

The FDA completed an inspection of Shandong Lukang Shelile Pharmaceutical Co., Ltd. on May 30, 2025 in Jining. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Veterinary.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 30, 2025
Fiscal Year
2025
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Jining (China)